[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100455794":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":19,"centralContacts":20,"locations":26,"responsibleParty":41,"collaborators":19,"id":45,"slug":46,"hasResults":47,"nctId":48,"briefTitle":49,"officialTitle":49,"acronym":19,"eligibilityCriteria":50,"healthyVolunteers":47,"sex":51,"minAge":19,"maxAge":19,"enrollmentInfo":52,"targetDuration":19,"studyType":55,"phases":56,"briefSummary":58,"conditions":59,"keywords":61,"overallStatus":28,"whyStopped":19,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":68,"completionDateStruct":70,"leadSponsor":72,"locationsCount":73},{"fullName":5,"class":6},"Pamukkale University","OTHER",[8],{"label":9,"type":10,"description":9,"interventionNames":11},"intracochlear prf administration group","EXPERIMENTAL",[12],"Drug: intracochlear platelet rich fibrin administration",[14],{"type":15,"name":16,"description":17,"armGroupLabels":18,"otherNames":19},"DRUG","intracochlear platelet rich fibrin administration","intracochlear platelet rich fibrin administration during routine cochlear implantation surgery",[9],null,[21],{"name":22,"role":23,"phone":24,"phoneExt":19,"email":25},"Fazil N Ardic, MD","CONTACT","902582965799","fnardic@pau.edu.tr",[27],{"facility":5,"status":28,"city":29,"state":19,"zip":30,"country":31,"countryCode":19,"cosmosGeoPoint":32,"geoPoint":37,"contacts":38},"RECRUITING","Denizli","20070","Turkey (Türkiye)",{"type":33,"coordinates":34},"Point",[35,36],29.0875,37.77417,{"lat":36,"lon":35},[39],{"name":22,"role":23,"phone":40,"phoneExt":19,"email":25},"+902582965799",{"type":42,"investigatorFullName":43,"investigatorTitle":44,"investigatorAffiliation":5,"oldNameTitle":19,"oldOrganization":19},"PRINCIPAL_INVESTIGATOR","Fazıl Necdet Ardıç","Head of Department of Otolaryngology","100455794","intracochlear-platelet-rich-fibrin-application-in-cochlear-implantation-100455794",false,"NCT05215197","Intracochlear Platelet-rich Fibrin Application in Cochlear Implantation","Inclusion Criteria:\n\n* Patients with sensorineural hearing loss\n* Patients who will have cochlear implant surgery with CI422 electrode\n\nExclusion Criteria:\n\n* Patients with cochlear abnormality\n* Patients with auditory neuropathy","ALL",{"count":53,"type":54},10,"ESTIMATED","INTERVENTIONAL",[57],"NA","Fibrosis due to surgical trauma is a common problem with cochlear implants. Fibrosis limits the effectiveness of implant and increases the power consumption. Our aim in this study is to benefit from the anti-inflammatory effects of autologous platelet-rich fibrin to reducing the fibrotic cascade.",[60],"Hearing Loss, Sensorineural",[62,63],"cochlear implant","platelet rich fibrin","2024-12-24",{"date":66,"type":67},"2024-12-27","ACTUAL",{"date":69,"type":67},"2022-01-31",{"date":71,"type":54},"2025-12-20",{"name":5,"class":6},1]